FDA unveils product development priorities

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 2006年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：15N / +
页数：2
相关论文
共 50 条
  • [1] FDA unveils guidance for biosimilar development
    Wechsler, Jill
    FORMULARY, 2012, 47 (03) : 96 - 96
  • [2] FDA Unveils Radiation Initiative
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 19N - 19N
  • [3] FDA Strategic Priorities
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) : 28N - 28N
  • [4] The FDA and scientific priorities
    Califf, Robert M.
    SCIENCE, 2022, 377 (6609) : 905 - 905
  • [5] FDA targets misconduct in new product development
    Reactions Weekly, 2009, 1265 (1) : 2 - 2
  • [6] FDA unveils regulatory science plan
    Kondro, Wayne
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (13) : E1014 - E1015
  • [7] FDA examines its priorities
    Hileman, B
    CHEMICAL & ENGINEERING NEWS, 2000, 78 (10) : 35 - 36
  • [8] Six Priorities for Investment in Snow Research and Product Development
    Hurwitz, Margaret M.
    Baxter, S.
    Brown, B.
    Carman, J.
    Dale, J.
    Draper, C.
    Horsfall, F.
    Hughes, M.
    Gerth, J.
    Kapnick, S.
    Olheiser, C.
    Olsen, M.
    Stachelski, C.
    Vincent, M.
    Webb, R. S.
    Zdrojewski, J.
    BULLETIN OF THE AMERICAN METEOROLOGICAL SOCIETY, 2020, 101 (11) : E2025 - E2029
  • [9] FDA encourages innovation in Biotech manufacturing and product development
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2006, 19 (05) : 26 - +
  • [10] FDA unveils searchable adverse events system
    Asher Mullard
    Nature Reviews Drug Discovery, 2017, 16 : 743 - 743
12345